RT Book, Section
A1 Ciccone, Charles D.
SR Print(0)
ID 1134172096
T1 Ibritumomab Tiuxetan
T2 Davis's Drug Guide for Rehabilitation Professionals
YR 2016
FD 2016
PB F. A. Davis Company
PP New York, NY
SN 9780803625891
LK fadavispt.mhmedical.com/content.aspx?aid=1134172096
RD 2024/04/19
AB ibritumomab  tiuxetan  (i-bri-too-mo-mab  tye-uks-i-tan)ZevalinClassificationTherapeutic:  antineoplasticsPharmacologic:  monoclonal  antibodies,  radioisotopes